Cipla (BOM:500087) Net Change in Cash : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1992. Start your Free Trial

What is Cipla Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Cipla's Net Change in Cash for the three months ended in Mar. 2025 was ₹0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Cipla Net Change in Cash Historical Data

The historical data trend for Cipla's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla Net Change in Cash Chart

Cipla Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Change in Cash

Get a 7-Day Free Trial

1,413.00

-1,323.20

-967.80

-489.90

303.10

Cipla Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-	-	-	-	-

Cipla Net Change in Cash Calculation

Cipla's Net Change in Cash for the fiscal year that ended in Mar. 2025 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	50049.8	+	-36911.4	+	-12927.9	+	92.6
	=	303

Cipla's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0 + 0 + 0 + 0

= 0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Cipla's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipla Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (BOM:500087) » Definitions » Net Change in Cash

Comparable Companies

NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 BOM:532321 NSE:DIVISLAB NSE:AUROPHARMA BOM:500488 NSE:ALKEM BOM:532296 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506

Traded in Other Exchanges

CIPLA:India

Address

Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.cipla.com

Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

Cipla Headlines

No Headlines